Trial intelligence / Profile preview

Optimisation of Peri-operative Cardiovascular Management to Improve Surgical Outcome (Optimise Trial)

2009-009596-35Phase 4Completed

Sponsor
Queen Mary's, University of London
Start
Apr 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dopexamine in complications of surgical procedures and Perioperative cardiovascular instability (PCVI) (2 arms), sponsored by Queen Mary's, University of London. Started Apr 2009; status: completed.

02

Drugs

dopexamine
03

Conditions

complications of surgical proceduresPerioperative cardiovascular instability (PCVI)

Beyond the preview

Go deeper on 2009-009596-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-009596-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call